The Avivia approach
Avivia product pipeline
|Fosfestrol||Uro-oncology - Prostate Cancer||Pre-registration|
|Calbi||Gastro-enterology - Bile Acid Diarrhea||Pre-clinical development|
|MCC||Pharmaceutical Technology - Excipients||Partnering|
|Buruli FDC||Tropical diseases - Buruli||Formulation|
|Metronidazole MR||Gastro-enterology - Pouchitis||Clinical development|
|Oxytone Sublingual||Gynaecology - Postpartum hemmorrhage||Clinical development|
Partnering with Avivia
Avivia is open to evaluate any partnering proposition, whether it is related to one of our internal development programs listed in the table above, or whether it is related to a product program suggested by a third party for co-development. We favor synergistic partnerships aimed at accelerating the development process and at expanding commercial opportunities with win-win for all parties involved.
If you are interested to learn more about one of our proprietary development programs or if you have a partnering opportunity you would like to discuss further, please don’t hesitate and get in contact with our business development and partnering team!
Hans Platteeuw, CEO Avivia